European confederation of medical mycology expert consult—An ECMM excellence center initiative

Summary Objectives Difficult‐to‐treat invasive fungal infections require infectious diseases expert consultation to improve treatment outcome and increase survival rates. Methods The European Confederation of Medical Mycology (ECMM) intends to provide expert help free of charge by a newly founded EC...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Mycoses 2020-06, Vol.63 (6), p.566-572
Hauptverfasser: Koehler, Philipp, Denis, Blandine, Denning, David W., Gangneux, Jean‐Pierre, Hoenigl, Martin, Kontoyiannis, Dimitrios P., Krause, Robert, Lagrou, Katrien, Lass‐Flörl, Cornelia, Maertens, Johan, Mareković, Ivana, Meis, Jacques F., Molina, Jean‐Michel, Pleško, Sanja, Prattes, Juergen, Rath, Peter‐Michael, Rautemaa‐Richardson, Riina, Richardson, Malcolm, Segal, Esther, Seidel, Danila, Spriet, Isabel, Steinmann, Joerg, Verweij, Paul E., Cornely, Oliver A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 572
container_issue 6
container_start_page 566
container_title Mycoses
container_volume 63
creator Koehler, Philipp
Denis, Blandine
Denning, David W.
Gangneux, Jean‐Pierre
Hoenigl, Martin
Kontoyiannis, Dimitrios P.
Krause, Robert
Lagrou, Katrien
Lass‐Flörl, Cornelia
Maertens, Johan
Mareković, Ivana
Meis, Jacques F.
Molina, Jean‐Michel
Pleško, Sanja
Prattes, Juergen
Rath, Peter‐Michael
Rautemaa‐Richardson, Riina
Richardson, Malcolm
Segal, Esther
Seidel, Danila
Spriet, Isabel
Steinmann, Joerg
Verweij, Paul E.
Cornely, Oliver A.
description Summary Objectives Difficult‐to‐treat invasive fungal infections require infectious diseases expert consultation to improve treatment outcome and increase survival rates. Methods The European Confederation of Medical Mycology (ECMM) intends to provide expert help free of charge by a newly founded ECMM Expert Consultation Service for medical centres around the globe seeking advice when there is no fungal infection consultant available. The expert consult will provide recommendations and broad expertise on difficult‐to‐treat invasive fungal infections (eg azole‐resistant Aspergillus species, Candida auris, mucormycosis) to improve diagnostic and therapeutic management and outcome. Results The initiative plans global outreach through video conferencing between ECMM Excellence Centers and treating physicians. FungiScope® registries will be used to structure case information and to evaluate the impact of the collegial advice system at regular intervals. Advice will follow recent guidelines, and EQUAL Scores will be used to measure guideline adherence. Conclusions Infectious diseases expert consultation should be an integral component of care for patients with difficult‐to‐treat invasive fungal infections. The ECMM Expert Consult will attend to this matter on a global scale.
doi_str_mv 10.1111/myc.13076
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_02565458v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2377991321</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4886-b74c2a21875faa1718280d6c9de1663bd09512db5ab1c1df194e7e85688b428b3</originalsourceid><addsrcrecordid>eNp1kc-O0zAQhy0EYsvCgRdAkbjAIbse_8-xqgqL1IoLHDgZx5mAV6ldnGShNx6CJ-RJcOmySEj4Ysnz6fPMbwh5CvQCyrncHfwFcKrVPbIAwZuaSqrvkwVtOK-1oPqMPBrHa0pBN0w9JGecgQEp1IJ8XM857dHFyqfYY4fZTSHFKvXVDrvg3VAVexrSp0OF3_aYpyM4zsP08_uPZazWq-22FDwOA0aPlcc4Ya5CDFMopht8TB70bhjxye19Tt6_Wr9bXdWbt6_frJab2gtjVN1q4ZkrbWnZOwcaDDO0U77pEJTibUcbCaxrpWvBQ9dDI1CjkcqYVjDT8nPy8uT97Aa7z2Hn8sEmF-zVcmOPb5RJJYU0N1DYFyd2n9OXGcfJ7sJ4HMFFTPNoGde6aaCkVNDn_6DXac6xTGKZoEpoDkb9_dznNI4Z-7sOgNrjimwJ0f5eUWGf3RrntkR8R_7ZSQEuT8DXMODh_ya7_bA6KX8B4gqaaA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2406473186</pqid></control><display><type>article</type><title>European confederation of medical mycology expert consult—An ECMM excellence center initiative</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Koehler, Philipp ; Denis, Blandine ; Denning, David W. ; Gangneux, Jean‐Pierre ; Hoenigl, Martin ; Kontoyiannis, Dimitrios P. ; Krause, Robert ; Lagrou, Katrien ; Lass‐Flörl, Cornelia ; Maertens, Johan ; Mareković, Ivana ; Meis, Jacques F. ; Molina, Jean‐Michel ; Pleško, Sanja ; Prattes, Juergen ; Rath, Peter‐Michael ; Rautemaa‐Richardson, Riina ; Richardson, Malcolm ; Segal, Esther ; Seidel, Danila ; Spriet, Isabel ; Steinmann, Joerg ; Verweij, Paul E. ; Cornely, Oliver A.</creator><creatorcontrib>Koehler, Philipp ; Denis, Blandine ; Denning, David W. ; Gangneux, Jean‐Pierre ; Hoenigl, Martin ; Kontoyiannis, Dimitrios P. ; Krause, Robert ; Lagrou, Katrien ; Lass‐Flörl, Cornelia ; Maertens, Johan ; Mareković, Ivana ; Meis, Jacques F. ; Molina, Jean‐Michel ; Pleško, Sanja ; Prattes, Juergen ; Rath, Peter‐Michael ; Rautemaa‐Richardson, Riina ; Richardson, Malcolm ; Segal, Esther ; Seidel, Danila ; Spriet, Isabel ; Steinmann, Joerg ; Verweij, Paul E. ; Cornely, Oliver A. ; European Confederation of Medical Mycology (ECMM)</creatorcontrib><description>Summary Objectives Difficult‐to‐treat invasive fungal infections require infectious diseases expert consultation to improve treatment outcome and increase survival rates. Methods The European Confederation of Medical Mycology (ECMM) intends to provide expert help free of charge by a newly founded ECMM Expert Consultation Service for medical centres around the globe seeking advice when there is no fungal infection consultant available. The expert consult will provide recommendations and broad expertise on difficult‐to‐treat invasive fungal infections (eg azole‐resistant Aspergillus species, Candida auris, mucormycosis) to improve diagnostic and therapeutic management and outcome. Results The initiative plans global outreach through video conferencing between ECMM Excellence Centers and treating physicians. FungiScope® registries will be used to structure case information and to evaluate the impact of the collegial advice system at regular intervals. Advice will follow recent guidelines, and EQUAL Scores will be used to measure guideline adherence. Conclusions Infectious diseases expert consultation should be an integral component of care for patients with difficult‐to‐treat invasive fungal infections. The ECMM Expert Consult will attend to this matter on a global scale.</description><identifier>ISSN: 0933-7407</identifier><identifier>EISSN: 1439-0507</identifier><identifier>DOI: 10.1111/myc.13076</identifier><identifier>PMID: 32181546</identifier><language>eng</language><publisher>Germany: Wiley Subscription Services, Inc</publisher><subject>Antifungal Agents - therapeutic use ; aspergillosis ; azole‐resistance ; Candida auris ; Candidemia ; candidosis ; Consultants ; cryptococcosis ; Disease Management ; Europe ; Fungal infections ; fusariosis ; Guideline Adherence ; Humans ; Infectious Disease Medicine - methods ; Infectious Disease Medicine - organization &amp; administration ; Infectious diseases ; Invasive Fungal Infections - drug therapy ; Life Sciences ; Mucormycosis ; Mycology - methods ; Mycology - organization &amp; administration ; Mycoses - drug therapy ; Mycoses - microbiology ; Referral and Consultation - organization &amp; administration ; Registries ; Treatment Outcome</subject><ispartof>Mycoses, 2020-06, Vol.63 (6), p.566-572</ispartof><rights>2020 The Authors. published by Blackwell Verlag GmbH</rights><rights>2020 The Authors. Mycoses published by Blackwell Verlag GmbH.</rights><rights>2020. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Attribution - NonCommercial - NoDerivatives</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4886-b74c2a21875faa1718280d6c9de1663bd09512db5ab1c1df194e7e85688b428b3</citedby><cites>FETCH-LOGICAL-c4886-b74c2a21875faa1718280d6c9de1663bd09512db5ab1c1df194e7e85688b428b3</cites><orcidid>0000-0002-3471-4285 ; 0000-0002-8051-2940 ; 0000-0003-4257-5980 ; 0000-0002-1653-2824 ; 0000-0001-6656-3648 ; 0000-0001-9599-3137 ; 0000-0001-5672-9552 ; 0000-0002-6711-8754 ; 0000-0002-7386-7495 ; 0000-0001-6342-0676 ; 0000-0002-3181-3667 ; 0000-0001-8668-1350 ; 0000-0001-5729-4511 ; 0000-0003-3253-6080 ; 0000-0001-5626-2251 ; 0000-0002-1071-6040 ; 0000-0003-2101-2601 ; 0000-0002-4974-5607 ; 0000-0003-1366-0123 ; 0000-0001-5751-9311 ; 0000-0002-2946-7785 ; 0000-0002-8600-9860 ; 0000-0003-4388-3117</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fmyc.13076$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fmyc.13076$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32181546$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://univ-rennes.hal.science/hal-02565458$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Koehler, Philipp</creatorcontrib><creatorcontrib>Denis, Blandine</creatorcontrib><creatorcontrib>Denning, David W.</creatorcontrib><creatorcontrib>Gangneux, Jean‐Pierre</creatorcontrib><creatorcontrib>Hoenigl, Martin</creatorcontrib><creatorcontrib>Kontoyiannis, Dimitrios P.</creatorcontrib><creatorcontrib>Krause, Robert</creatorcontrib><creatorcontrib>Lagrou, Katrien</creatorcontrib><creatorcontrib>Lass‐Flörl, Cornelia</creatorcontrib><creatorcontrib>Maertens, Johan</creatorcontrib><creatorcontrib>Mareković, Ivana</creatorcontrib><creatorcontrib>Meis, Jacques F.</creatorcontrib><creatorcontrib>Molina, Jean‐Michel</creatorcontrib><creatorcontrib>Pleško, Sanja</creatorcontrib><creatorcontrib>Prattes, Juergen</creatorcontrib><creatorcontrib>Rath, Peter‐Michael</creatorcontrib><creatorcontrib>Rautemaa‐Richardson, Riina</creatorcontrib><creatorcontrib>Richardson, Malcolm</creatorcontrib><creatorcontrib>Segal, Esther</creatorcontrib><creatorcontrib>Seidel, Danila</creatorcontrib><creatorcontrib>Spriet, Isabel</creatorcontrib><creatorcontrib>Steinmann, Joerg</creatorcontrib><creatorcontrib>Verweij, Paul E.</creatorcontrib><creatorcontrib>Cornely, Oliver A.</creatorcontrib><creatorcontrib>European Confederation of Medical Mycology (ECMM)</creatorcontrib><title>European confederation of medical mycology expert consult—An ECMM excellence center initiative</title><title>Mycoses</title><addtitle>Mycoses</addtitle><description>Summary Objectives Difficult‐to‐treat invasive fungal infections require infectious diseases expert consultation to improve treatment outcome and increase survival rates. Methods The European Confederation of Medical Mycology (ECMM) intends to provide expert help free of charge by a newly founded ECMM Expert Consultation Service for medical centres around the globe seeking advice when there is no fungal infection consultant available. The expert consult will provide recommendations and broad expertise on difficult‐to‐treat invasive fungal infections (eg azole‐resistant Aspergillus species, Candida auris, mucormycosis) to improve diagnostic and therapeutic management and outcome. Results The initiative plans global outreach through video conferencing between ECMM Excellence Centers and treating physicians. FungiScope® registries will be used to structure case information and to evaluate the impact of the collegial advice system at regular intervals. Advice will follow recent guidelines, and EQUAL Scores will be used to measure guideline adherence. Conclusions Infectious diseases expert consultation should be an integral component of care for patients with difficult‐to‐treat invasive fungal infections. The ECMM Expert Consult will attend to this matter on a global scale.</description><subject>Antifungal Agents - therapeutic use</subject><subject>aspergillosis</subject><subject>azole‐resistance</subject><subject>Candida auris</subject><subject>Candidemia</subject><subject>candidosis</subject><subject>Consultants</subject><subject>cryptococcosis</subject><subject>Disease Management</subject><subject>Europe</subject><subject>Fungal infections</subject><subject>fusariosis</subject><subject>Guideline Adherence</subject><subject>Humans</subject><subject>Infectious Disease Medicine - methods</subject><subject>Infectious Disease Medicine - organization &amp; administration</subject><subject>Infectious diseases</subject><subject>Invasive Fungal Infections - drug therapy</subject><subject>Life Sciences</subject><subject>Mucormycosis</subject><subject>Mycology - methods</subject><subject>Mycology - organization &amp; administration</subject><subject>Mycoses - drug therapy</subject><subject>Mycoses - microbiology</subject><subject>Referral and Consultation - organization &amp; administration</subject><subject>Registries</subject><subject>Treatment Outcome</subject><issn>0933-7407</issn><issn>1439-0507</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>EIF</sourceid><recordid>eNp1kc-O0zAQhy0EYsvCgRdAkbjAIbse_8-xqgqL1IoLHDgZx5mAV6ldnGShNx6CJ-RJcOmySEj4Ysnz6fPMbwh5CvQCyrncHfwFcKrVPbIAwZuaSqrvkwVtOK-1oPqMPBrHa0pBN0w9JGecgQEp1IJ8XM857dHFyqfYY4fZTSHFKvXVDrvg3VAVexrSp0OF3_aYpyM4zsP08_uPZazWq-22FDwOA0aPlcc4Ya5CDFMopht8TB70bhjxye19Tt6_Wr9bXdWbt6_frJab2gtjVN1q4ZkrbWnZOwcaDDO0U77pEJTibUcbCaxrpWvBQ9dDI1CjkcqYVjDT8nPy8uT97Aa7z2Hn8sEmF-zVcmOPb5RJJYU0N1DYFyd2n9OXGcfJ7sJ4HMFFTPNoGde6aaCkVNDn_6DXac6xTGKZoEpoDkb9_dznNI4Z-7sOgNrjimwJ0f5eUWGf3RrntkR8R_7ZSQEuT8DXMODh_ya7_bA6KX8B4gqaaA</recordid><startdate>202006</startdate><enddate>202006</enddate><creator>Koehler, Philipp</creator><creator>Denis, Blandine</creator><creator>Denning, David W.</creator><creator>Gangneux, Jean‐Pierre</creator><creator>Hoenigl, Martin</creator><creator>Kontoyiannis, Dimitrios P.</creator><creator>Krause, Robert</creator><creator>Lagrou, Katrien</creator><creator>Lass‐Flörl, Cornelia</creator><creator>Maertens, Johan</creator><creator>Mareković, Ivana</creator><creator>Meis, Jacques F.</creator><creator>Molina, Jean‐Michel</creator><creator>Pleško, Sanja</creator><creator>Prattes, Juergen</creator><creator>Rath, Peter‐Michael</creator><creator>Rautemaa‐Richardson, Riina</creator><creator>Richardson, Malcolm</creator><creator>Segal, Esther</creator><creator>Seidel, Danila</creator><creator>Spriet, Isabel</creator><creator>Steinmann, Joerg</creator><creator>Verweij, Paul E.</creator><creator>Cornely, Oliver A.</creator><general>Wiley Subscription Services, Inc</general><general>Wiley</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>M7N</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><orcidid>https://orcid.org/0000-0002-3471-4285</orcidid><orcidid>https://orcid.org/0000-0002-8051-2940</orcidid><orcidid>https://orcid.org/0000-0003-4257-5980</orcidid><orcidid>https://orcid.org/0000-0002-1653-2824</orcidid><orcidid>https://orcid.org/0000-0001-6656-3648</orcidid><orcidid>https://orcid.org/0000-0001-9599-3137</orcidid><orcidid>https://orcid.org/0000-0001-5672-9552</orcidid><orcidid>https://orcid.org/0000-0002-6711-8754</orcidid><orcidid>https://orcid.org/0000-0002-7386-7495</orcidid><orcidid>https://orcid.org/0000-0001-6342-0676</orcidid><orcidid>https://orcid.org/0000-0002-3181-3667</orcidid><orcidid>https://orcid.org/0000-0001-8668-1350</orcidid><orcidid>https://orcid.org/0000-0001-5729-4511</orcidid><orcidid>https://orcid.org/0000-0003-3253-6080</orcidid><orcidid>https://orcid.org/0000-0001-5626-2251</orcidid><orcidid>https://orcid.org/0000-0002-1071-6040</orcidid><orcidid>https://orcid.org/0000-0003-2101-2601</orcidid><orcidid>https://orcid.org/0000-0002-4974-5607</orcidid><orcidid>https://orcid.org/0000-0003-1366-0123</orcidid><orcidid>https://orcid.org/0000-0001-5751-9311</orcidid><orcidid>https://orcid.org/0000-0002-2946-7785</orcidid><orcidid>https://orcid.org/0000-0002-8600-9860</orcidid><orcidid>https://orcid.org/0000-0003-4388-3117</orcidid></search><sort><creationdate>202006</creationdate><title>European confederation of medical mycology expert consult—An ECMM excellence center initiative</title><author>Koehler, Philipp ; Denis, Blandine ; Denning, David W. ; Gangneux, Jean‐Pierre ; Hoenigl, Martin ; Kontoyiannis, Dimitrios P. ; Krause, Robert ; Lagrou, Katrien ; Lass‐Flörl, Cornelia ; Maertens, Johan ; Mareković, Ivana ; Meis, Jacques F. ; Molina, Jean‐Michel ; Pleško, Sanja ; Prattes, Juergen ; Rath, Peter‐Michael ; Rautemaa‐Richardson, Riina ; Richardson, Malcolm ; Segal, Esther ; Seidel, Danila ; Spriet, Isabel ; Steinmann, Joerg ; Verweij, Paul E. ; Cornely, Oliver A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4886-b74c2a21875faa1718280d6c9de1663bd09512db5ab1c1df194e7e85688b428b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Antifungal Agents - therapeutic use</topic><topic>aspergillosis</topic><topic>azole‐resistance</topic><topic>Candida auris</topic><topic>Candidemia</topic><topic>candidosis</topic><topic>Consultants</topic><topic>cryptococcosis</topic><topic>Disease Management</topic><topic>Europe</topic><topic>Fungal infections</topic><topic>fusariosis</topic><topic>Guideline Adherence</topic><topic>Humans</topic><topic>Infectious Disease Medicine - methods</topic><topic>Infectious Disease Medicine - organization &amp; administration</topic><topic>Infectious diseases</topic><topic>Invasive Fungal Infections - drug therapy</topic><topic>Life Sciences</topic><topic>Mucormycosis</topic><topic>Mycology - methods</topic><topic>Mycology - organization &amp; administration</topic><topic>Mycoses - drug therapy</topic><topic>Mycoses - microbiology</topic><topic>Referral and Consultation - organization &amp; administration</topic><topic>Registries</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Koehler, Philipp</creatorcontrib><creatorcontrib>Denis, Blandine</creatorcontrib><creatorcontrib>Denning, David W.</creatorcontrib><creatorcontrib>Gangneux, Jean‐Pierre</creatorcontrib><creatorcontrib>Hoenigl, Martin</creatorcontrib><creatorcontrib>Kontoyiannis, Dimitrios P.</creatorcontrib><creatorcontrib>Krause, Robert</creatorcontrib><creatorcontrib>Lagrou, Katrien</creatorcontrib><creatorcontrib>Lass‐Flörl, Cornelia</creatorcontrib><creatorcontrib>Maertens, Johan</creatorcontrib><creatorcontrib>Mareković, Ivana</creatorcontrib><creatorcontrib>Meis, Jacques F.</creatorcontrib><creatorcontrib>Molina, Jean‐Michel</creatorcontrib><creatorcontrib>Pleško, Sanja</creatorcontrib><creatorcontrib>Prattes, Juergen</creatorcontrib><creatorcontrib>Rath, Peter‐Michael</creatorcontrib><creatorcontrib>Rautemaa‐Richardson, Riina</creatorcontrib><creatorcontrib>Richardson, Malcolm</creatorcontrib><creatorcontrib>Segal, Esther</creatorcontrib><creatorcontrib>Seidel, Danila</creatorcontrib><creatorcontrib>Spriet, Isabel</creatorcontrib><creatorcontrib>Steinmann, Joerg</creatorcontrib><creatorcontrib>Verweij, Paul E.</creatorcontrib><creatorcontrib>Cornely, Oliver A.</creatorcontrib><creatorcontrib>European Confederation of Medical Mycology (ECMM)</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>Mycoses</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Koehler, Philipp</au><au>Denis, Blandine</au><au>Denning, David W.</au><au>Gangneux, Jean‐Pierre</au><au>Hoenigl, Martin</au><au>Kontoyiannis, Dimitrios P.</au><au>Krause, Robert</au><au>Lagrou, Katrien</au><au>Lass‐Flörl, Cornelia</au><au>Maertens, Johan</au><au>Mareković, Ivana</au><au>Meis, Jacques F.</au><au>Molina, Jean‐Michel</au><au>Pleško, Sanja</au><au>Prattes, Juergen</au><au>Rath, Peter‐Michael</au><au>Rautemaa‐Richardson, Riina</au><au>Richardson, Malcolm</au><au>Segal, Esther</au><au>Seidel, Danila</au><au>Spriet, Isabel</au><au>Steinmann, Joerg</au><au>Verweij, Paul E.</au><au>Cornely, Oliver A.</au><aucorp>European Confederation of Medical Mycology (ECMM)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>European confederation of medical mycology expert consult—An ECMM excellence center initiative</atitle><jtitle>Mycoses</jtitle><addtitle>Mycoses</addtitle><date>2020-06</date><risdate>2020</risdate><volume>63</volume><issue>6</issue><spage>566</spage><epage>572</epage><pages>566-572</pages><issn>0933-7407</issn><eissn>1439-0507</eissn><abstract>Summary Objectives Difficult‐to‐treat invasive fungal infections require infectious diseases expert consultation to improve treatment outcome and increase survival rates. Methods The European Confederation of Medical Mycology (ECMM) intends to provide expert help free of charge by a newly founded ECMM Expert Consultation Service for medical centres around the globe seeking advice when there is no fungal infection consultant available. The expert consult will provide recommendations and broad expertise on difficult‐to‐treat invasive fungal infections (eg azole‐resistant Aspergillus species, Candida auris, mucormycosis) to improve diagnostic and therapeutic management and outcome. Results The initiative plans global outreach through video conferencing between ECMM Excellence Centers and treating physicians. FungiScope® registries will be used to structure case information and to evaluate the impact of the collegial advice system at regular intervals. Advice will follow recent guidelines, and EQUAL Scores will be used to measure guideline adherence. Conclusions Infectious diseases expert consultation should be an integral component of care for patients with difficult‐to‐treat invasive fungal infections. The ECMM Expert Consult will attend to this matter on a global scale.</abstract><cop>Germany</cop><pub>Wiley Subscription Services, Inc</pub><pmid>32181546</pmid><doi>10.1111/myc.13076</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-3471-4285</orcidid><orcidid>https://orcid.org/0000-0002-8051-2940</orcidid><orcidid>https://orcid.org/0000-0003-4257-5980</orcidid><orcidid>https://orcid.org/0000-0002-1653-2824</orcidid><orcidid>https://orcid.org/0000-0001-6656-3648</orcidid><orcidid>https://orcid.org/0000-0001-9599-3137</orcidid><orcidid>https://orcid.org/0000-0001-5672-9552</orcidid><orcidid>https://orcid.org/0000-0002-6711-8754</orcidid><orcidid>https://orcid.org/0000-0002-7386-7495</orcidid><orcidid>https://orcid.org/0000-0001-6342-0676</orcidid><orcidid>https://orcid.org/0000-0002-3181-3667</orcidid><orcidid>https://orcid.org/0000-0001-8668-1350</orcidid><orcidid>https://orcid.org/0000-0001-5729-4511</orcidid><orcidid>https://orcid.org/0000-0003-3253-6080</orcidid><orcidid>https://orcid.org/0000-0001-5626-2251</orcidid><orcidid>https://orcid.org/0000-0002-1071-6040</orcidid><orcidid>https://orcid.org/0000-0003-2101-2601</orcidid><orcidid>https://orcid.org/0000-0002-4974-5607</orcidid><orcidid>https://orcid.org/0000-0003-1366-0123</orcidid><orcidid>https://orcid.org/0000-0001-5751-9311</orcidid><orcidid>https://orcid.org/0000-0002-2946-7785</orcidid><orcidid>https://orcid.org/0000-0002-8600-9860</orcidid><orcidid>https://orcid.org/0000-0003-4388-3117</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0933-7407
ispartof Mycoses, 2020-06, Vol.63 (6), p.566-572
issn 0933-7407
1439-0507
language eng
recordid cdi_hal_primary_oai_HAL_hal_02565458v1
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Antifungal Agents - therapeutic use
aspergillosis
azole‐resistance
Candida auris
Candidemia
candidosis
Consultants
cryptococcosis
Disease Management
Europe
Fungal infections
fusariosis
Guideline Adherence
Humans
Infectious Disease Medicine - methods
Infectious Disease Medicine - organization & administration
Infectious diseases
Invasive Fungal Infections - drug therapy
Life Sciences
Mucormycosis
Mycology - methods
Mycology - organization & administration
Mycoses - drug therapy
Mycoses - microbiology
Referral and Consultation - organization & administration
Registries
Treatment Outcome
title European confederation of medical mycology expert consult—An ECMM excellence center initiative
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T10%3A04%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=European%20confederation%20of%20medical%20mycology%20expert%20consult%E2%80%94An%20ECMM%20excellence%20center%20initiative&rft.jtitle=Mycoses&rft.au=Koehler,%20Philipp&rft.aucorp=European%20Confederation%20of%20Medical%20Mycology%20(ECMM)&rft.date=2020-06&rft.volume=63&rft.issue=6&rft.spage=566&rft.epage=572&rft.pages=566-572&rft.issn=0933-7407&rft.eissn=1439-0507&rft_id=info:doi/10.1111/myc.13076&rft_dat=%3Cproquest_hal_p%3E2377991321%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2406473186&rft_id=info:pmid/32181546&rfr_iscdi=true